– Nomad Health, the leading digital marketplace for temporary healthcare jobs, announced the completion of $63m in new equity and debt financing.
– Adams Street Partners led, and all existing investors participated, including Icon Ventures, Polaris Partners, RRE Ventures, .406 Ventures, First Round Capital, and Silicon Valley Bank.
– With this financing, the business has raised over $100m since the company’s inception in 2015.
– The funding will be used to support Nomad Health’s explosive growth, allowing the company to double down on efforts to hire, invest in the technology platform, and grow its national footprint.
– As the demands on the healthcare system have reached historic levels during the COVID-19 pandemic, the need and urgency for temporary healthcare staffing solutions has substantially increased.

– ClosedLoop.ai from Austin develops a healthcare’s data science platform using artificial intelligence to improve outcomes and reduce costs.
– Series B $34m round was led by Telstra Ventures with participation from Breyer Capital, Greycroft Ventures, .406 Ventures, and Healthfirst, with participation from angel investors Adam Boehler (former director of CMMI & CEO of Rubicon Founders) and Sam Palmisano (former CEO of IBM).
– The new investment will be aimed at further expanding the reach of its artificial intelligence solutions.

– retrain.ai, a NYC-based Talent Intelligence Platform, raised an additional $7m in funding.
– Backers included current investors Square Peg, Hetz Ventures, TechAviv, .406 Ventures and Schusterman Family Investments and new investor Splunk Ventures.
– The company intends to use the funds for U.S. expansion, hiring of key talent and product development.

– Cortica from San Diego CA is focused on clinical services for autism and other neurodevelopmental conditions.
– Series C $60m funding round was led by Longitude Capital with participation from 406 Ventures, Adam Boehler, Questa Capital and Aperture Venture Partners and Silicon Valley Bank.
– The new financing will be used to accelerate growth, expand centers across multiple states, and investigate novel drug, device, and diagnostic technologies through sponsored and NIH-funded research.

– retrain.ai, a NYC-based provider of a talent intelligence platform that uses AI and Machine Learning to help organizations upskill, retrain and place professionals in new roles, closed a $9M Series A funding round.
– Square Peg made the investment, following their $4M seed round in September 2020, led by Hetz Ventures, with TechAviv and .406 Ventures participating.
– The company will use the funds to accelerate growth and to expand its team.

– Tausight raised $20m in Series A funding to help solve one of the most challenging responsibilities of healthcare CIOs and CISOs: ensuring the confidentiality, integrity, and availability of patients’ protected health information (PHI).
– The funding round was co-led by existing investors Polaris Partners and Flare Capital Partners, alongside new investor .406 Ventures.
– Tausight will help healthcare provider CIOs, CISOs, and their IT organizations better secure clinical workflows when clinicians access and use PHI.
– The company will use the funding to expand its go-to-market team and further build out its healthcare-specific solution for exposing the hidden vulnerabilities in clinical workflows that can put patient data at risk.

– Redox, the company making healthcare data useful, today announced it has raised $45m in Series D funding.
– The round was led by global private equity firm Adams Street Partners, with participation from Avenir and existing investors Battery Ventures, .406 Ventures, and RRE Ventures.
– This funding was preceded by a consistent pattern of acceleration. With integrations booming by 300% and the company surpassing 1,000 live connections on the Redox network in October 2020, Redox continues on an exponential trajectory.

– Equip, a health tech company pioneering a program that virtually delivers evidence-based eating disorder treatment to families at home, today announced it has closed $13m in Series A financing, bringing its total funds raised to date to $17m.
– The Series A round was led by Optum Ventures, with participation from new investor .406 Ventures and existing investor F-Prime Capital, who led the company’s prior Seed round.
– Equip’s mission is to make gold-standard eating disorder treatment accessible to all people through Family-Based Treatment (FBT) – the standard of care which empowers families to help their loved ones through recovery.